Selected research
Market Outlook & Growth Opportunities
Global Exosome Analytical Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Exosome Analytical Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Analytical Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Exosome Analytical Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Exosome Analytical Service market include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Exosome Diagnostics, Beijing Enze Kangtai Biotechnology, System Biosciences, Qiagen and Norgen Biotek Corp., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Exosome Analytical Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Exosome Analytical Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Exosome Analytical Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Exosome Analytical Service market.
Exosome Analytical Service Segment by Company
Codiak Biosciences
Aethlon Medical
NanoSomix
Aruna Bio
Exosome Diagnostics
Beijing Enze Kangtai Biotechnology
System Biosciences
Qiagen
Norgen Biotek Corp.
HansaBioMed Life Sciences
AMS Biotechnology
Sistemic Scotland
NanoView Biosciences
Malvern Panalytical
Evomic Science
BioIVT
Codiak Biosciences
Creative Biolabs
Evox Therapeutics
Precision NanoSystems
Unisensor SA
VolitionRx Limited
Capricor Therapeutics
Pure Biologics
Janssen Biotech
Exosome Analytical Service Segment by Type
Exosome Isolation and Purification
Exosome Quantification
Exosome Characterization
Exosome Cargo Analysis
Exosome Uptake and Signaling Analysis
Exosome Functional Studies
Exosome Analytical Service Segment by Application
Biopharmaceutical R&D
Clinical Medicine
Life Science Research
Agricultural Technology
Other
Exosome Analytical Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Exosome Analytical Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Exosome Analytical Service key companies, revenue, market share, and recent developments.
3. To split the Exosome Analytical Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Exosome Analytical Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Exosome Analytical Service significant trends, drivers, influence factors in global and regions.
6. To analyze Exosome Analytical Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Analytical Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Analytical Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Analytical Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exosome Analytical Service industry.
Chapter 3: Detailed analysis of Exosome Analytical Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Exosome Analytical Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Exosome Analytical Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Exosome Isolation and Purification
- Exosome Quantification
- Exosome Characterization
- Exosome Cargo Analysis
- Exosome Uptake and Signaling Analysis
- Exosome Functional Studies
Applications
- Biopharmaceutical R&D
- Clinical Medicine
- Life Science Research
- Agricultural Technology
- Other
Companies covered
- Codiak Biosciences
- Aethlon Medical
- NanoSomix
- Aruna Bio
- Exosome Diagnostics
- Beijing Enze Kangtai Biotechnology
- System Biosciences
- Qiagen
- Norgen Biotek Corp.
- HansaBioMed Life Sciences
- AMS Biotechnology
- Sistemic Scotland
- NanoView Biosciences
- Malvern Panalytical
- Evomic Science
- BioIVT
- Codiak Biosciences
- Creative Biolabs
- Evox Therapeutics
- Precision NanoSystems
- Unisensor SA
- VolitionRx Limited
- Capricor Therapeutics
- Pure Biologics
- Janssen Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Exosome Analytical Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Exosome Analytical Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Exosome Analytical Service Market Dynamics
- 2.1 Exosome Analytical Service Industry Trends
- 2.2 Exosome Analytical Service Industry Drivers
- 2.3 Exosome Analytical Service Industry Opportunities and Challenges
- 2.4 Exosome Analytical Service Industry Restraints
3 Exosome Analytical Service Market by Company
- 3.1 Global Exosome Analytical Service Company Revenue Ranking in 2025
- 3.2 Global Exosome Analytical Service Revenue by Company (2021-2026)
- 3.3 Global Exosome Analytical Service Company Ranking (2024-2026)
- 3.4 Global Exosome Analytical Service Company Manufacturing Base and Headquarters
- 3.5 Global Exosome Analytical Service Company Product Type and Application
- 3.6 Global Exosome Analytical Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Exosome Analytical Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Exosome Analytical Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Exosome Analytical Service Market by Type
- 4.1 Exosome Analytical Service Type Introduction
- 4.1.1 Exosome Isolation and Purification
- 4.1.2 Exosome Quantification
- 4.1.3 Exosome Characterization
- 4.1.4 Exosome Cargo Analysis
- 4.1.5 Exosome Uptake and Signaling Analysis
- 4.1.6 Exosome Functional Studies
- 4.2 Global Exosome Analytical Service Sales Value by Type
- 4.2.1 Global Exosome Analytical Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Exosome Analytical Service Sales Value by Type (2021-2032)
- 4.2.3 Global Exosome Analytical Service Sales Value Share by Type (2021-2032)
5 Exosome Analytical Service Market by Application
- 5.1 Exosome Analytical Service Application Introduction
- 5.1.1 Biopharmaceutical R&D
- 5.1.2 Clinical Medicine
- 5.1.3 Life Science Research
- 5.1.4 Agricultural Technology
- 5.1.5 Other
- 5.2 Global Exosome Analytical Service Sales Value by Application
- 5.2.1 Global Exosome Analytical Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Exosome Analytical Service Sales Value by Application (2021-2032)
- 5.2.3 Global Exosome Analytical Service Sales Value Share by Application (2021-2032)
6 Exosome Analytical Service Regional Value Analysis
- 6.1 Global Exosome Analytical Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Exosome Analytical Service Sales Value by Region (2021-2032)
- 6.2.1 Global Exosome Analytical Service Sales Value by Region: 2021-2026
- 6.2.2 Global Exosome Analytical Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Exosome Analytical Service Sales Value (2021-2032)
- 6.3.2 North America Exosome Analytical Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Exosome Analytical Service Sales Value (2021-2032)
- 6.4.2 Europe Exosome Analytical Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Exosome Analytical Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Exosome Analytical Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Exosome Analytical Service Sales Value (2021-2032)
- 6.6.2 South America Exosome Analytical Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Exosome Analytical Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Exosome Analytical Service Sales Value Share by Country, 2025 VS 2032
7 Exosome Analytical Service Country-level Value Analysis
- 7.1 Global Exosome Analytical Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Exosome Analytical Service Sales Value by Country (2021-2032)
- 7.2.1 Global Exosome Analytical Service Sales Value by Country (2021-2026)
- 7.2.2 Global Exosome Analytical Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Exosome Analytical Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Exosome Analytical Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Exosome Analytical Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Codiak Biosciences
- 8.1.1 Codiak Biosciences Company Information
- 8.1.2 Codiak Biosciences Business Overview
- 8.1.3 Codiak Biosciences Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 8.1.5 Codiak Biosciences Recent Developments
- 8.2 Aethlon Medical
- 8.2.1 Aethlon Medical Company Information
- 8.2.2 Aethlon Medical Business Overview
- 8.2.3 Aethlon Medical Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Aethlon Medical Exosome Analytical Service Product Portfolio
- 8.2.5 Aethlon Medical Recent Developments
- 8.3 NanoSomix
- 8.3.1 NanoSomix Company Information
- 8.3.2 NanoSomix Business Overview
- 8.3.3 NanoSomix Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.3.4 NanoSomix Exosome Analytical Service Product Portfolio
- 8.3.5 NanoSomix Recent Developments
- 8.4 Aruna Bio
- 8.4.1 Aruna Bio Company Information
- 8.4.2 Aruna Bio Business Overview
- 8.4.3 Aruna Bio Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Aruna Bio Exosome Analytical Service Product Portfolio
- 8.4.5 Aruna Bio Recent Developments
- 8.5 Exosome Diagnostics
- 8.5.1 Exosome Diagnostics Company Information
- 8.5.2 Exosome Diagnostics Business Overview
- 8.5.3 Exosome Diagnostics Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Exosome Diagnostics Exosome Analytical Service Product Portfolio
- 8.5.5 Exosome Diagnostics Recent Developments
- 8.6 Beijing Enze Kangtai Biotechnology
- 8.6.1 Beijing Enze Kangtai Biotechnology Company Information
- 8.6.2 Beijing Enze Kangtai Biotechnology Business Overview
- 8.6.3 Beijing Enze Kangtai Biotechnology Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Beijing Enze Kangtai Biotechnology Exosome Analytical Service Product Portfolio
- 8.6.5 Beijing Enze Kangtai Biotechnology Recent Developments
- 8.7 System Biosciences
- 8.7.1 System Biosciences Company Information
- 8.7.2 System Biosciences Business Overview
- 8.7.3 System Biosciences Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.7.4 System Biosciences Exosome Analytical Service Product Portfolio
- 8.7.5 System Biosciences Recent Developments
- 8.8 Qiagen
- 8.8.1 Qiagen Company Information
- 8.8.2 Qiagen Business Overview
- 8.8.3 Qiagen Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Qiagen Exosome Analytical Service Product Portfolio
- 8.8.5 Qiagen Recent Developments
- 8.9 Norgen Biotek Corp.
- 8.9.1 Norgen Biotek Corp. Company Information
- 8.9.2 Norgen Biotek Corp. Business Overview
- 8.9.3 Norgen Biotek Corp. Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Norgen Biotek Corp. Exosome Analytical Service Product Portfolio
- 8.9.5 Norgen Biotek Corp. Recent Developments
- 8.10 HansaBioMed Life Sciences
- 8.10.1 HansaBioMed Life Sciences Company Information
- 8.10.2 HansaBioMed Life Sciences Business Overview
- 8.10.3 HansaBioMed Life Sciences Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.10.4 HansaBioMed Life Sciences Exosome Analytical Service Product Portfolio
- 8.10.5 HansaBioMed Life Sciences Recent Developments
- 8.11 AMS Biotechnology
- 8.11.1 AMS Biotechnology Company Information
- 8.11.2 AMS Biotechnology Business Overview
- 8.11.3 AMS Biotechnology Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.11.4 AMS Biotechnology Exosome Analytical Service Product Portfolio
- 8.11.5 AMS Biotechnology Recent Developments
- 8.12 Sistemic Scotland
- 8.12.1 Sistemic Scotland Company Information
- 8.12.2 Sistemic Scotland Business Overview
- 8.12.3 Sistemic Scotland Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Sistemic Scotland Exosome Analytical Service Product Portfolio
- 8.12.5 Sistemic Scotland Recent Developments
- 8.13 NanoView Biosciences
- 8.13.1 NanoView Biosciences Company Information
- 8.13.2 NanoView Biosciences Business Overview
- 8.13.3 NanoView Biosciences Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.13.4 NanoView Biosciences Exosome Analytical Service Product Portfolio
- 8.13.5 NanoView Biosciences Recent Developments
- 8.14 Malvern Panalytical
- 8.14.1 Malvern Panalytical Company Information
- 8.14.2 Malvern Panalytical Business Overview
- 8.14.3 Malvern Panalytical Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Malvern Panalytical Exosome Analytical Service Product Portfolio
- 8.14.5 Malvern Panalytical Recent Developments
- 8.15 Evomic Science
- 8.15.1 Evomic Science Company Information
- 8.15.2 Evomic Science Business Overview
- 8.15.3 Evomic Science Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Evomic Science Exosome Analytical Service Product Portfolio
- 8.15.5 Evomic Science Recent Developments
- 8.16 BioIVT
- 8.16.1 BioIVT Company Information
- 8.16.2 BioIVT Business Overview
- 8.16.3 BioIVT Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.16.4 BioIVT Exosome Analytical Service Product Portfolio
- 8.16.5 BioIVT Recent Developments
- 8.17 Codiak Biosciences
- 8.17.1 Codiak Biosciences Company Information
- 8.17.2 Codiak Biosciences Business Overview
- 8.17.3 Codiak Biosciences Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Codiak Biosciences Exosome Analytical Service Product Portfolio
- 8.17.5 Codiak Biosciences Recent Developments
- 8.18 Creative Biolabs
- 8.18.1 Creative Biolabs Company Information
- 8.18.2 Creative Biolabs Business Overview
- 8.18.3 Creative Biolabs Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Creative Biolabs Exosome Analytical Service Product Portfolio
- 8.18.5 Creative Biolabs Recent Developments
- 8.19 Evox Therapeutics
- 8.19.1 Evox Therapeutics Company Information
- 8.19.2 Evox Therapeutics Business Overview
- 8.19.3 Evox Therapeutics Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.19.4 Evox Therapeutics Exosome Analytical Service Product Portfolio
- 8.19.5 Evox Therapeutics Recent Developments
- 8.20 Precision NanoSystems
- 8.20.1 Precision NanoSystems Company Information
- 8.20.2 Precision NanoSystems Business Overview
- 8.20.3 Precision NanoSystems Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Precision NanoSystems Exosome Analytical Service Product Portfolio
- 8.20.5 Precision NanoSystems Recent Developments
- 8.21 Unisensor SA
- 8.21.1 Unisensor SA Company Information
- 8.21.2 Unisensor SA Business Overview
- 8.21.3 Unisensor SA Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.21.4 Unisensor SA Exosome Analytical Service Product Portfolio
- 8.21.5 Unisensor SA Recent Developments
- 8.22 VolitionRx Limited
- 8.22.1 VolitionRx Limited Company Information
- 8.22.2 VolitionRx Limited Business Overview
- 8.22.3 VolitionRx Limited Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.22.4 VolitionRx Limited Exosome Analytical Service Product Portfolio
- 8.22.5 VolitionRx Limited Recent Developments
- 8.23 Capricor Therapeutics
- 8.23.1 Capricor Therapeutics Company Information
- 8.23.2 Capricor Therapeutics Business Overview
- 8.23.3 Capricor Therapeutics Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.23.4 Capricor Therapeutics Exosome Analytical Service Product Portfolio
- 8.23.5 Capricor Therapeutics Recent Developments
- 8.24 Pure Biologics
- 8.24.1 Pure Biologics Company Information
- 8.24.2 Pure Biologics Business Overview
- 8.24.3 Pure Biologics Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.24.4 Pure Biologics Exosome Analytical Service Product Portfolio
- 8.24.5 Pure Biologics Recent Developments
- 8.25 Janssen Biotech
- 8.25.1 Janssen Biotech Company Information
- 8.25.2 Janssen Biotech Business Overview
- 8.25.3 Janssen Biotech Exosome Analytical Service Revenue and Gross Margin (2021-2026)
- 8.25.4 Janssen Biotech Exosome Analytical Service Product Portfolio
- 8.25.5 Janssen Biotech Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst